Comparison of Fenofibrate and Niacin in Patients With Hypertriglyceridemia and Low High-Density Lipoprotein (HDL)-Cholesterol

Hypertriglyceridemia With Low HDL-cholesterol Clinical Trial

Status Completed

Clinical Trial Summary

The purpose of the study is to compare the efficacy and tolerability of fenofibrate 160 mg and niacin 1500 mg in patients with hypertriglyceridemia and low HDL-cholesterol. The primary end point is the percent change of apoB/A1 and the secondary end points are other lipid parameters and biomarkers.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Hypertriglyceridemia
• Hypertriglyceridemia With Low HDL-cholesterol

• NCT number: NCT01122355
• Study type: Interventional
• Source: Yonsei University
• Status: Completed
• Phase: Phase 4
• Start date: February 2009
• Completion date: January 2010